811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Weatherford International plc appointed Anuj Dhruv, 43, as Executive Vice President and Chief Financial Officer, effective April 21, 2025, and Arunava Mitra left the role on the same date. The filing gives no financial results, but a change in CFO is a significant leadership event for shareholders to track.
Anuj Dhruv, 43, previously led finance and strategy for LyondellBasell's Global Olefins and Polyolefins segment, a $29 billion revenue segment, from November 2022 to April 2025
Dhruv's 2025 base salary is $570,000, with a long-term incentive award of $1,767,000 and a sign-on equity award of $1,000,000
Arunava Mitra left the company effective April 21, 2025; the filing states his departure is not the result of any dispute over accounting practices or financial statements
Weatherford reported first-quarter 2025 revenue of $1,193 million, down 12% from a year earlier, and net income attributable to the company of $76 million, down 32%. Management said market conditions have skewed more negatively over the past few weeks and that it has scaled back its expectations for customer activity through the rest of 2025.
Q1 2025 revenue $1,193 million, down 12% year-over-year; operating income $142 million, down 39%
Diluted income per share $1.03, compared with $1.50 in Q1 2024
Management scaled back expectations for activity levels for the rest of 2025 and remains confident in increasing adjusted free cash flow conversion for the full year
Board declared a $0.25 per share cash dividend, payable June 5, 2025, to holders of record as of May 6, 2025
PennyMac Mortgage Investment Trust (NYSE: PMT) reported a net loss attributable to common shareholders of $0.8 million, or $(0.01) per diluted share, for the first quarter of 2025, compared with net income of $36.1 million, or $0.41 per diluted share, in the fourth quarter of 2024. The company said income excluding market-driven value changes was strong, but net fair value declines from interest rate volatility and credit spread widening offset it, and book value per common share fell to $15.43 from $15.87.
Net investment income was $44.5 million, down from $107.9 million in the prior quarter.
Book value per common share was $15.43 at March 31, 2025, versus $15.87 at December 31, 2024.
Net loan servicing fees were a loss of $27.2 million, compared with income of $207.4 million in the prior quarter.
A cash dividend of $0.40 per common share is payable April 25, 2025, to holders of record as of April 11, 2025.
OPENLANE's board appointed Bradley Herring as Executive Vice President and Chief Financial Officer, effective May 27, 2025. Herring most recently served as CFO of Enfusion, Inc. until April 21, 2025, and will lead the company's financial, reporting and investor-facing functions, including capital investment strategy.
Bradley Herring appointed EVP and CFO effective May 27, 2025, reporting to CEO Peter Kelly
Herring was CFO of Enfusion, Inc. from December 2022 to April 21, 2025, and CFO of Shift4 Payments, Inc. from October 2019 to August 2022
Employment agreement provides a one-time $100,000 cash sign-on award, subject to full repayment if he resigns within two years
Agree Realty reported first-quarter 2025 net income per share down 2.0% to $0.42, while Core FFO per share rose 3.1% to $1.04 and AFFO per share rose 3.0% to $1.06. The company raised its full-year 2025 investment volume guidance to $1.3 billion to $1.5 billion and its AFFO per share guidance to $4.27 to $4.30. For shareholders, the higher AFFO guidance points to a higher expected cash earnings per share, although GAAP net income per share fell slightly.
Q1 2025 total revenues were $169.2 million, compared with $149.5 million in Q1 2024.
Net income attributable to common stockholders rose 5.0% to $45.1 million, but net income per diluted share fell to $0.42 from $0.43.
2025 AFFO per share guidance was revised to $4.27 to $4.30 from $4.26 to $4.30.
2025 investment volume guidance was raised to $1.3 billion to $1.5 billion from $1.1 billion to $1.3 billion.
Hope Bancorp reported first-quarter 2025 net income of $21.1 million, or $0.17 per diluted share, down from $24.3 million, or $0.20 per share, in the fourth quarter of 2024. The company also completed its acquisition of Territorial Bancorp effective April 2, 2025, and declared a quarterly dividend of $0.14 per share, which matters to shareholders because lower earnings were reported alongside a larger combined bank and a continued dividend.
Net income was $21.1 million, or $0.17 per diluted share, versus $24.3 million, or $0.20, in Q4 2024 and $25.9 million, or $0.21, in Q1 2024.
Excluding notable items, net income was $22.9 million, or $0.19 per diluted share.
Net interest income was $100.8 million, down 1% from $102.1 million in Q4 2024; the tangible common equity ratio rose to 10.20%.
Quarterly dividend of $0.14 per common share is payable on or about May 16, 2025, to holders of record on May 2, 2025.
Kimberly-Clark reported first quarter 2025 net sales of $4.8 billion, down 6.0 percent, and diluted EPS of $1.70 versus $1.91 a year earlier, with adjusted EPS of $1.93, down 4.0 percent. The company lowered its 2025 outlook, now expecting adjusted operating profit to be flat to positive on a constant-currency basis, down from high single-digit growth, citing higher global supply chain costs.
Net sales $4.8 billion, down 6.0 percent; organic sales down 1.6 percent
Diluted EPS $1.70 vs. $1.91 prior year; adjusted EPS $1.93, down 4.0 percent
2025 adjusted operating profit now flat to positive on constant-currency basis, versus prior expectation of high single-digit growth
2025 adjusted free cash flow now approximately $2 billion, versus previously more than $2 billion
Invesco agreed on April 21, 2025 to buy back $1 billion of its 5.9% Series A preferred stock from MassMutual, a significant shareholder owning about 18.2% of common shares, at a 15% premium to liquidation preference. The all-cash deal, funded through debt financing, is expected to close in May 2025 and is expected to be earnings accretive beginning in the second half of 2025, while the company also raised its quarterly common dividend.
Repurchase of $1 billion of Series A preferred stock at a 15% premium to liquidation preference, expected to close in May 2025
Funded through debt financing; MassMutual will continue to hold $3 billion of preferred stock after the repurchase
Invesco expects the repurchase to be earnings accretive beginning in the second half of 2025
Quarterly common dividend increased from $0.205 to $0.210 per share; Barings and MassMutual also announced a U.S. wealth partnership with MassMutual's initial $650 million support
Northrop Grumman reported first-quarter 2025 sales of $9.5 billion, down 7 percent, and diluted EPS of $3.32 versus $6.32 a year earlier, after a $477 million pre-tax loss provision on the B-21 program. The company cut its 2025 segment operating income guidance to $4.2 billion-$4.35 billion from $4.65 billion-$4.8 billion and its MTM-adjusted EPS guidance to $24.95-$25.35 from $27.85-$28.25, while reaffirming its sales and free cash flow guidance. Lower profit expectations for 2025 are the key development for shareholders.
Q1 2025 sales were $9.5 billion, down from $10.1 billion in Q1 2024.
Diluted EPS was $3.32 versus $6.32, including a $2.74 per share impact from the B-21 loss provision.
2025 MTM-adjusted EPS guidance was lowered to $24.95-$25.35 from $27.85-$28.25.
2025 sales guidance of $42.0 billion-$42.5 billion and free cash flow guidance of $2.85 billion-$3.25 billion were reaffirmed.
Quest Diagnostics reported first quarter 2025 revenue of $2.65 billion, up 12.1% from a year earlier, and reported diluted EPS of $1.94, up 12.8%. The company raised its full-year 2025 reported diluted EPS outlook to $8.62 to $8.87 from $8.34 to $8.59 and reaffirmed its revenue and adjusted EPS guidance, which matters to shareholders because the earnings outlook moved up while the top-line outlook held.
Q1 2025 net revenues $2.65 billion, up 12.1%; organic requisition volume fell 0.9%
Reported diluted EPS $1.94, up 12.8%; adjusted diluted EPS $2.21, up 8.3%
Full-year 2025 reported diluted EPS now expected at $8.62 to $8.87, up from $8.34 to $8.59
Full-year 2025 revenue guidance of $10.70 billion to $10.85 billion and adjusted diluted EPS of $9.55 to $9.80 unchanged
Invesco reported first-quarter 2025 diluted EPS of $0.38, up 22.6% from $0.31 a year earlier but down 17.4% from $0.46 in the fourth quarter of 2024. Operating revenues rose 3.7% year over year to $1,529.2 million, while the company also announced a $1 billion repurchase of its Series A Preferred Stock held by MassMutual, expected in May, and a higher quarterly common dividend of $0.21 per share.
Q1 2025 diluted EPS $0.38 vs. $0.31 in Q1 2024 and $0.46 in Q4 2024; adjusted diluted EPS $0.44
Operating revenues $1,529.2 million, up 3.7% year over year, down 4.0% from Q4 2024
Net long-term inflows of $17.6 billion; ending AUM $1,844.8 billion
$1 billion preferred stock repurchase from MassMutual expected in May; quarterly common dividend raised to $0.21 per share, payable June 3, 2025
Equifax reported first-quarter 2025 revenue of $1.442 billion, up 4%, and said it was $37 million above the midpoint of its February guidance. Net income attributable to Equifax rose 7% to $133.1 million, and diluted EPS rose 6% to $1.06. The board authorized a $3 billion share repurchase program and a 28% dividend increase to $0.50 per share, while maintaining full-year 2025 guidance.
Q1 2025 revenue $1.442 billion, up 4% reported and 5% local currency; U.S. Mortgage revenue up 7%
Net income attributable to Equifax $133.1 million, up 7%; diluted EPS $1.06, up 6%; adjusted EPS $1.53, up 2%
Board authorized up to $3 billion in share repurchases with no stated expiration date, announced April 21, 2025
Quarterly dividend raised 28% to $0.50 per share, payable June 13, 2025; full-year 2025 guidance maintained
Synchrony reported first quarter 2025 net earnings of $757 million, or $1.89 per diluted share, down 41% from $1.3 billion, or $3.14 per share, a year earlier. The prior-year figure included an $802 million post-tax gain on the Pets Best sale; excluding that gain, the company says adjusted earnings rose 54%. The board approved a new $2.5 billion share repurchase authorization through June 30, 2026, and raised the quarterly dividend 20% to $0.30 per share starting in the second quarter of 2025.
Net earnings were $757 million, or $1.89 per diluted share, versus $1.3 billion, or $3.14 per share, in Q1 2024
Q1 2024 included an $802 million post-tax Pets Best gain on sale; adjusted Q1 2024 net earnings were $491 million, or $1.18 per share
Net revenue fell 22.5% to $3.7 billion from $4.8 billion, largely reflecting the prior-year Pets Best gain in other income
Board approved a $2.5 billion repurchase authorization through June 30, 2026, and a dividend of $0.30 per share from Q2 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.